Meta Pixel

News and Announcements

Calima Energy relists after successful $38M merger with BlackSpur

  • Published May 03, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

“Calima has the large scale and emerging play of Montney gas in North East British Columbia and the low-cost but high economic and cash flow generative oil projects in Alberta (Brooks and Thorsby).

We have big plans for the coming 2 years, targeting 3,400 boe/d by year end 2021 and 5,500 boe/d by year end 2022, from low risk appraisal and development drilling. Couple that with our M&A plans to pick off low hanging fruit, and we are anticipating rapid growth.

Facilities and infrastructure have been built up already to handle close to 10,000 boe/d, and pre COVID we were producing 5,000 boe/d plus.

Jordan Kevol, CEO, Calima Energy

Register Interest

Executive Summary

Calima Energy Limited is an ASX listed oil and gas producer with assets in Western Canada. Calima is focused on high growth exploration and production and has assembled an exciting and growing inventory of drilling locations across a sizeable land base within British Columbia and Alberta.

Investment Highlights

Calima is a development story for the Brooks and Thorsby production assets with combined 2P reserves of 22.5 MMboe.

The highly cost-efficient wells will generate an EBITDA of $25M USD in year 1 based on 3,400 boe/d and a base oil price of $US60.

These cashflows will enable the development of the company’s world-class Montney landholding which currently has 2C Resources of 192.4 MMboe.

Calima will also use capital generated to seek out value-rich acquisitions in interesting and complementary assets across North America.

Investment Offering

Calima is relisting today following the successful $38M merger with BlackSpur.

View their ASX listing or click below to find out more about the company.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now